Clinical results and impact on circulating endothelial cells (CEC) of treatment with combinations of interferon-alpha(l alpha), thalidomide (T) and celecoxib (C) in patients with solid tumors / A. Rocca, C.N.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 1527-7755. - 23:16 Supplement(2005 Jun 01), pp. 3193.239S-3193.239S. (41. Annual Meeting of the American Society of Clinical Oncology : May, 13th - 17th Orlando (FL, USA) 2005).
Clinical results and impact on circulating endothelial cells (CEC) of treatment with combinations of interferon-alpha(l alpha), thalidomide (T) and celecoxib (C) in patients with solid tumors
G. Curigliano;A. Milani;F. De BraudUltimo
2005
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JCO GC.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
139.49 kB
Formato
Adobe PDF
|
139.49 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
